These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8709102)

  • 1. Deconvolution of combinatorial libraries for drug discovery: experimental comparison of pooling strategies.
    Wilson-Lingardo L; Davis PW; Ecker DJ; Hébert N; Acevedo O; Sprankle K; Brennan T; Schwarcz L; Freier SM; Wyatt JR
    J Med Chem; 1996 Jul; 39(14):2720-6. PubMed ID: 8709102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconvolution of combinatorial libraries for Drug discovery: theoretical comparison of pooling strategies.
    Konings DA; Wyatt JR; Ecker DJ; Freier SM
    J Med Chem; 1996 Jul; 39(14):2710-9. PubMed ID: 8709101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for rapid deconvolution of combinational libraries: comparative evaluation using a model system.
    Konings DA; Wyatt JR; Ecker DJ; Freier SM
    J Med Chem; 1997 Dec; 40(26):4386-95. PubMed ID: 9435908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Mutational SURF': a strategy for improving lead compounds identified from combinatorial libraries.
    Freier SM; Konings DA; Wyatt JR; Ecker DJ
    Bioorg Med Chem; 1996 May; 4(5):717-25. PubMed ID: 8804538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution.
    Yamazaki K; Kusunose N; Fujita K; Sato H; Asano S; Dan A; Kanaoka M
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1371-9. PubMed ID: 16337379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis.
    Shipe WD; Sharik SS; Barrow JC; McGaughey GB; Theberge CR; Uslaner JM; Yan Y; Renger JJ; Smith SM; Coleman PJ; Cox CD
    J Med Chem; 2015 Oct; 58(19):7888-94. PubMed ID: 26378882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium-independent phospholipase A2 in the regulation of calcium influx into Jurkat cells.
    Zabłocki K; Duszyński J
    Pol J Pharmacol; 1999; 51(2):163-6. PubMed ID: 10425645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical and experimental relationships between percent inhibition and IC50 data observed in high-throughput screening.
    Gubler H; Schopfer U; Jacoby E
    J Biomol Screen; 2013 Jan; 18(1):1-13. PubMed ID: 22853931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug leads from combinatorial phosphodiester libraries.
    Davis PW; Vickers TA; Wilson-Lingardo L; Wyatt JR; Guinosso CJ; Sanghvi YS; DeBaets EA; Acevedo OL; Cook PD; Ecker DJ
    J Med Chem; 1995 Oct; 38(22):4363-6. PubMed ID: 7473564
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of a positional scanning library of pentamers of N-alkylglycines assisted by microwave activation and validation via the identification of trypsin inhibitors.
    Messeguer J; Cortés N; García-Sanz N; Navarro-Vendrell G; Ferrer-Montiel A; Messeguer A
    J Comb Chem; 2008; 10(6):974-80. PubMed ID: 18847288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
    Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
    J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of a method for the study of drugs which inhibit phospholipase A2].
    Alcaraz MJ
    Arch Farmacol Toxicol; 1985 Aug; 11(2):73-8. PubMed ID: 3002289
    [No Abstract]   [Full Text] [Related]  

  • 13. SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity.
    Thirkettle J; Alvarez E; Boyd H; Brown M; Diez E; Hueso J; Elson S; Fulston M; Gershater C; Morata ML; Perez P; Ready S; Sanchez-Puelles JM; Sheridan R; Stefanska A; Warr S
    J Antibiot (Tokyo); 2000 Jul; 53(7):664-9. PubMed ID: 10994807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of anthelmintic preparations on phospholipase A2 activity].
    Tsukerman AI; Kaplan EIa; Shumakovich IE; Dobretsov GE; Mikhaĭlitsyn FS
    Med Parazitol (Mosk); 1982; 51(5):41-5. PubMed ID: 7177050
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors.
    Brullo C; Massa M; Rocca M; Rotolo C; Guariento S; Rivera D; Ricciarelli R; Fedele E; Fossa P; Bruno O
    J Med Chem; 2014 Aug; 57(16):7061-72. PubMed ID: 25126889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
    Tanaka K; Arita H
    Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of combinatorial library methods in cancer research and drug discovery.
    Lam KS
    Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Nitrobenzimidazole derivatives: potential phosphodiesterase inhibitors: synthesis and structure-activity relationship.
    Khan KM; Shah Z; Ahmad VU; Ambreen N; Khan M; Taha M; Rahim F; Noreen S; Perveen S; Choudhary MI; Voelter W
    Bioorg Med Chem; 2012 Feb; 20(4):1521-6. PubMed ID: 22264761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
    Bridonneau P; Chang YF; O'Connell D; Gill SC; Snyder DW; Johnson L; Goodson T; Herron DK; Parma DH
    J Med Chem; 1998 Mar; 41(6):778-86. PubMed ID: 9526554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.